"El diseño de estrategias de crecimiento está en nuestro ADN"

Central Nervous System Treatment Market Size, Share, Trends & Industry Analysis, By Disease Type (Neurovascular Diseases, Neurodegenerative Diseases, Mental Health, Infectious Diseases, and Others), By Drug Class (Immunomodulatory Drugs, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Antidepressants, Others) By Drug Type (Biologics and Non-biologics), By Distribution Channel (Hospital Pharmacies, Retail Farmacias), y pronóstico regional, 2025-2032

Última actualización: November 17, 2025 | Formato: PDF | ID de informe: FBI103973

 


Central Nervous System Treatment Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 160
Descargar muestra gratuita

    man icon
    Mail icon
Servicios de asesoramiento sobre crecimiento
    ¿Cómo podemos ayudarle a descubrir nuevas oportunidades y escalar más rápido?
Clientes
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann